NASDAQ:CMRA

Comera Life Sciences Holdings Stock Insider Trading

etoro logo Buy CMRA
*Your capital is at risk
$0.0001
+0.0000000000 (+0.00000300000009%)
At Close: Jul 31, 2026

Comera Life Sciences Holdings Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 13B and sold 0 CMRA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 13B shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Dec 03, 2023
Buy
Common Stock, par value $0.0001 per share
Freebird Partners Lp
10 Percent Owner
10% Owner 0
Value: $0
Dec 03, 2023
Buy
Common Stock, par value $0.0001 per share
Freebird Partners Lp
10 Percent Owner
10% Owner 0
Value: $0
Nov 27, 2023
Buy
Common Stock
P-Purchase
Campbell Michael Gerard
EVP & CFO
C-Suite Officer 10 000
Value: $708
Nov 27, 2023
Buy
Common Stock
P-Purchase
Campbell Michael Gerard
EVP & CFO
C-Suite Officer 10 000
Value: $708
Nov 15, 2023
Buy
Common Stock
J-Other
Wexler William A.
Director
Director 3 113
Value: $0
Nov 15, 2023
Buy
Common Stock
J-Other
Wexler William A.
Director
Director 3 113
Value: $0
Nov 09, 2023
Buy
Stock Option (Right to Purchase)
A-Award
Flowers Kirsten
Director
Director 111 494
Value: $35.7K
Nov 09, 2023
Buy
Stock Option (Right to Purchase)
A-Award
Banerjee Sirshendu Roopom
Director
Director 122 487
Value: $39.2K
Nov 09, 2023
Buy
Stock Option (Right to Purchase)
A-Award
Sullivan Edward Aloysius Jr.
Director
Director 127 198
Value: $40.8K
Nov 09, 2023
Buy
Stock Option (Right to Purchase)
A-Award
Flowers Kirsten
Director
Director 111 494
Value: $35.7K
Nov 09, 2023
Buy
Stock Option (Right to Purchase)
A-Award
Banerjee Sirshendu Roopom
Director
Director 122 487
Value: $39.2K
Nov 09, 2023
Buy
Stock Option (Right to Purchase)
A-Award
Sullivan Edward Aloysius Jr.
Director
Director 127 198
Value: $40.8K
Nov 07, 2023
Buy
Common Stock
J-Other
Clarke Dorothy J
Director 0
Value: $0
Nov 07, 2023
Buy
Stock Option (Right to Purchase
A-Award
Clarke Dorothy J
Director
Director 14 200
Value: $5K
Nov 07, 2023
Buy
Common Stock
J-Other
Clarke Dorothy J
Director 0
Value: $0
Nov 07, 2023
Buy
Stock Option (Right to Purchase
A-Award
Clarke Dorothy J
Director
Director 14 200
Value: $5K
Oct 14, 2023
Buy
Stock Option (Right to Purchase)
A-Award
Mccourt Janice
Chief Business Officer
Officer 20 000
Value: $6K
Oct 14, 2023
Buy
Stock Option (Right to Purchase)
A-Award
Muni Neal
EVP & COO
C-Suite Officer 60 000
Value: $17.4K
Oct 14, 2023
Buy
Stock Option (Right to Purchase)
A-Award
Mccourt Janice
Chief Business Officer
Officer 20 000
Value: $6K
Oct 14, 2023
Buy
Stock Option (Right to Purchase)
A-Award
Muni Neal
EVP & COO
C-Suite Officer 60 000
Value: $17.4K
Sep 27, 2023
Buy
Stock Option (Right to Purchase)
A-Award
Hackman Jeffrey S.
See Remarks.
Officer 600 000
Value: $225.6K
Sep 27, 2023
Buy
Stock Option (Right to Purchase)
A-Award
Campbell Michael Gerard
EVP & CFO
C-Suite Officer 350 000
Value: $131.6K
Sep 27, 2023
Buy
Stock Option (Right to Purchase)
A-Award
Mahoney Robert Patrick
Chief Scientific Officer
Officer 300 000
Value: $112.8K
Sep 27, 2023
Buy
Stock Option (Right to Purchase)
A-Award
Mahoney Robert Patrick
Chief Scientific Officer
Officer 300 000
Value: $112.8K
Sep 27, 2023
Buy
Stock Option (Right to Purchase)
A-Award
Hackman Jeffrey S.
See Remarks.
Officer 600 000
Value: $225.6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT COMERA LIFE SCIENCES HOLDINGS, INC.
Comera Life Sciences Holdings
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis dis...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE